Historical record - last NADAC effective date: 2/22/2017

Product Information

QUETIAPINE FUMARATE 200 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2037 per EA under NDC 65862049399. Its NADAC has been published 170 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

QUETIAPINE FUMARATE 200 MG TAB

Quetiapine Fumarate
$0.2037per EA

Strength

200 mg/1

NDC

65862049399

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/22/2017

Active Ingredients

QUETIAPINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091388

FDA Approved

3/27/2012

TE Code

AB

On Market Since

3/27/2012

Pharmacological Classes

Price Statistics

The NADAC for QUETIAPINE FUMARATE 200 MG TAB has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 38.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2037 per EA
All-time high$0.3373 (Mar 12, 2014)
All-time low$0.2008 (Nov 23, 2016)
Median price$0.2551
Average price$0.2628
Largest weekly change+18.4% (Oct 29, 2014)
Weeks tracked170
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-38.6%

Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QUETIAPINE FUMARATE 200 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 200 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.2037 per EA (NDC 65862049399), effective Feb 22, 2017.

How has the price of QUETIAPINE FUMARATE 200 MG TAB changed over time?

Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 200 MG TAB has declined 38.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 200 MG TAB?

Since Nov 28, 2013, the NADAC for QUETIAPINE FUMARATE 200 MG TAB has ranged from a low of $0.2008 (Nov 23, 2016) to a high of $0.3373 (Mar 12, 2014), with a median of $0.2551 per EA.

Are there cheaper alternatives to QUETIAPINE FUMARATE 200 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 200 MG TAB, is $0.0857 per EA — about 58% below QUETIAPINE FUMARATE 200 MG TAB.

Who manufactures QUETIAPINE FUMARATE 200 MG TAB?

QUETIAPINE FUMARATE 200 MG TAB (NDC 65862049399) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.